Literature DB >> 3041313

Glucose metabolism alterations in Friedreich's ataxia.

G Finocchiaro1, G Baio, P Micossi, G Pozza, S di Donato.   

Abstract

We have characterized the abnormalities of glucose metabolism associated with Friedreich's ataxia (FA) by studying plasma glucose, insulin, growth hormone (GH), and glucagon before and after an oral glucose tolerance test (OGTT), an IV glucose load, and an IV arginine load, in 21 patients and in controls. Twelve patients were normotolerant (NT) to glucose, five glucose-intolerant (IT), and four diabetic (DM). Insulin secretion of IT patients was increased and delayed during OGTT. Interestingly, the insulin release during arginine load was significantly decreased in NT and IT as well as in DM patients. The GH response to OGTT was altered in IT patients. Plasma glucagon after an arginine load was significantly higher in patients than in controls. The results indicate that FA is associated with insulin resistance, beta-cell deficiency, and type I diabetes. These alterations might be genetically linked or metabolically related to the primary defect in FA. Their interplay or independent effects are responsible for abnormalities of glucose metabolism in FA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3041313     DOI: 10.1212/wnl.38.8.1292

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  32 in total

Review 1.  Multisystem manifestations of mitochondrial disorders.

Authors:  Stefano Di Donato
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

2.  Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.

Authors:  Mariana Igoillo-Esteve; Ana F Oliveira; Cristina Cosentino; Federica Fantuzzi; Céline Demarez; Sanna Toivonen; Amélie Hu; Satyan Chintawar; Miguel Lopes; Nathalie Pachera; Ying Cai; Baroj Abdulkarim; Myriam Rai; Lorella Marselli; Piero Marchetti; Mohammad Tariq; Jean-Christophe Jonas; Marina Boscolo; Massimo Pandolfo; Décio L Eizirik; Miriam Cnop
Journal:  JCI Insight       Date:  2020-01-30

3.  Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion.

Authors:  S I Bidichandani; T Ashizawa; P I Patel
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Common data elements for clinical research in Friedreich's ataxia.

Authors:  David R Lynch; Massimo Pandolfo; Jorg B Schulz; Susan Perlman; Martin B Delatycki; R Mark Payne; Robert Shaddy; Kenneth H Fischbeck; Jennifer Farmer; Paul Kantor; Subha V Raman; Lisa Hunegs; Joanne Odenkirchen; Kristy Miller; Petra Kaufmann
Journal:  Mov Disord       Date:  2012-12-12       Impact factor: 10.338

5.  Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

Authors:  R Lodi; J M Cooper; J L Bradley; D Manners; P Styles; D J Taylor; A H Schapira
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  Oligomerization propensity and flexibility of yeast frataxin studied by X-ray crystallography and small-angle X-ray scattering.

Authors:  Christopher A G Söderberg; Alexander V Shkumatov; Sreekanth Rajan; Oleksandr Gakh; Dmitri I Svergun; Grazia Isaya; Salam Al-Karadaghi
Journal:  J Mol Biol       Date:  2011-10-25       Impact factor: 5.469

7.  Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.

Authors:  Giovanni Coppola; Daniele Marmolino; Daning Lu; Qing Wang; Miriam Cnop; Myriam Rai; Fabio Acquaviva; Sergio Cocozza; Massimo Pandolfo; Daniel H Geschwind
Journal:  Hum Mol Genet       Date:  2009-04-17       Impact factor: 6.150

8.  PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.

Authors:  Daniele Marmolino; Mario Manto; Fabio Acquaviva; Paola Vergara; Ajay Ravella; Antonella Monticelli; Massimo Pandolfo
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 9.  Multicellular models of Friedreich ataxia.

Authors:  Hélène Puccio
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

10.  Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.

Authors:  Miriam Cnop; Mariana Igoillo-Esteve; Myriam Rai; Audrey Begu; Yasmina Serroukh; Chantal Depondt; Anyishai E Musuaya; Ihsane Marhfour; Laurence Ladrière; Xavier Moles Lopez; Dionysios Lefkaditis; Fabrice Moore; Jean-Pierre Brion; J Mark Cooper; Anthony H V Schapira; Anne Clark; Arnulf H Koeppen; Piero Marchetti; Massimo Pandolfo; Décio L Eizirik; Françoise Féry
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.